BMRN peer analysis
BioMarin (BMRN) against its competitors: price, today's move, 1-year return and market value side by side.
BMRN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALNY Alnylam | $157.89 | -4.31% | -64.88% | $22.10B |
| ASND Ascendis Pharma | $248.82 | -0.98% | 22.14% | $16.53B |
| BBIO BridgeBio Pharma | $74.31 | -0.85% | 17.26% | $14.60B |
| INSM Insmed | $109.43 | -2.80% | -43.66% | $24.70B |
| IONS Ionis Pharmaceuticals | $41.21 | -5.31% | -44.44% | $7.23B |
| PHAR Pharming Group | $12.13 | -1.06% | -9.55% | – |
| PTCT PTC Therapeutics | $60.84 | 1.45% | -10.67% | $5.01B |
| RARE Ultragenyx | $16.32 | 1.37% | -53.60% | $1.59B |
| TVTX Travere Therapeutics | $47.30 | -6.13% | 59.53% | – |
| VRTX Vertex | $564.99 | 1.09% | 34.56% | $141.65B |
| BMRN BioMarin | $53.67 | -8.27% | 3.39% | $11.33B |
- BMRN's peers: ALNY (Alnylam), ASND (Ascendis Pharma), BBIO (BridgeBio Pharma), INSM (Insmed), IONS (Ionis Pharmaceuticals), PHAR (Pharming Group), PTCT (PTC Therapeutics), RARE (Ultragenyx).
Updated 2026-11-03 01:49 UTC